메뉴 건너뛰기




Volumn 54, Issue 2, 2013, Pages 252-254

The impact of initial fludarabine therapy on transformation to Richter syndrome or prolymphocytic leukemia in patients with chronic lymphocytic leukemia: Analysis of an intergroup trial (CALGB 9011)

Author keywords

CLL; Fludarabine; Prolymphocytic; Richter

Indexed keywords

CHLORAMBUCIL; FLUDARABINE;

EID: 84872032663     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.710327     Document Type: Article
Times cited : (33)

References (22)
  • 1
    • 0000421361 scopus 로고
    • Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia
    • Richter M. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am JPathol 1928; 6:285-299.
    • (1928) Am JPathol , vol.6 , pp. 285-299
    • Richter, M.1
  • 3
    • 0017883241 scopus 로고
    • Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia
    • Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 1978; 41: 422-427.
    • (1978) Cancer , vol.41 , pp. 422-427
    • Armitage, J.O.1    Dick, F.R.2    Corder, M.P.3
  • 4
    • 0018833095 scopus 로고
    • Richter'ssyndrome in chronic lymphocytic leukemia
    • Foucar K, Rydell RE. Richter'ssyndrome in chronic lymphocytic leukemia. Cancer 1980; 46: 11C8-134.
    • (1980) Cancer , vol.46
    • Foucar, K.1    Rydell, R.E.2
  • 5
    • 0027484024 scopus 로고
    • Richter'ssyndrome: Areport on 39 patients
    • Robertson LE, Pugh W, O'Brien S, et al. Richter'ssyndrome: areport on 39 patients. JClin Oncol 1993; 11: 1985-1989.
    • (1993) JClin Oncol , vol.11 , pp. 1985-1989
    • Robertson, L.E.1    Pugh, W.2    O'Brien, S.3
  • 6
    • 0034649696 scopus 로고    scopus 로고
    • Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia
    • Rai KR, Peterson BL, Appelbaum FR, et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. NEngl JMed 2000; 343: 1750-1757.
    • (2000) NEngl JMed , vol.343 , pp. 1750-1757
    • Rai, K.R.1    Peterson, B.L.2    Appelbaum, F.R.3
  • 7
    • 4444368179 scopus 로고    scopus 로고
    • Second neoplasms in patients with chronic lymphocytic leukemia
    • Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004; 5: 215-223.
    • (2004) Curr Treat Options Oncol , vol.5 , pp. 215-223
    • Wiernik, P.H.1
  • 8
    • 60949087189 scopus 로고    scopus 로고
    • Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma
    • Tsimberidou AM, Wen W, McLaughlin P, et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. JClin Oncol 2009; 27: 904-910.
    • (2009) JClin Oncol , vol.27 , pp. 904-910
    • Tsimberidou, A.M.1    Wen, W.2    McLaughlin, P.3
  • 9
    • 0037106257 scopus 로고    scopus 로고
    • Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: Results of an intergroup study, cancer and leukemia group B 9011
    • Morrison VA, Rai KR, Peterson BL, et al. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. JClin Oncol 2002; 20: 3878-3884.
    • (2002) JClin Oncol , vol.20 , pp. 3878-3884
    • Morrison, V.A.1    Rai, K.R.2    Peterson, B.L.3
  • 10
    • 77954998779 scopus 로고    scopus 로고
    • Long-term survival analysis of the North American intergroup study C9011 comparing fludarabine (F) and chlorambucil (Cin previously untreated patients with chronic lymphocytic leukemia (CLL)
    • Abstract 536
    • Rai K, Peterson BL, Appelbaum FR, et al. Long-term survival analysis of the North American intergroup study C9011 comparing fludarabine (F) and chlorambucil (C) in previously untreated patients with chronic lymphocytic leukemia (CLL). Blood 2 009; 1 14(Suppl. 1): Abstract 536.
    • (2009) Blood , vol.114 , Issue.SUPPL. 1
    • Rai, K.1    Peterson, B.L.2    Appelbaum, F.R.3
  • 11
    • 0030890228 scopus 로고    scopus 로고
    • Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia
    • Jelic S, Jovanovic V, Milanovic N, et al. Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. Neoplasia 1997; 44: 63-68.
    • (1997) Neoplasia , vol.44 , pp. 63-68
    • Jelic, S.1    Jovanovic, V.2    Milanovic, N.3
  • 12
    • 0033566295 scopus 로고    scopus 로고
    • Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: Asingle institution study of 204 cases
    • Mauro FR, Foa R, Giannarelli D, et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: asingle institution study of 204 cases. Blood 1999; 94: 448-454.
    • (1999) Blood , vol.94 , pp. 448-454
    • Mauro, F.R.1    Foa, R.2    Giannarelli, D.3
  • 13
    • 47249117983 scopus 로고    scopus 로고
    • Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome
    • Rossi D, Cerri M, Capello D, et al. Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br JHaematol 2008; 142: 202-215.
    • (2008) Br JHaematol , vol.142 , pp. 202-215
    • Rossi, D.1    Cerri, M.2    Capello, D.3
  • 14
    • 0032529509 scopus 로고    scopus 로고
    • Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy
    • Keating MJ, O'Brien S, Lerner S, et al. Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998; 92: 1165-1171.
    • (1998) Blood , vol.92 , pp. 1165-1171
    • Keating, M.J.1    O'Brien, S.2    Lerner, S.3
  • 15
    • 13844255162 scopus 로고    scopus 로고
    • Richter'stransformation of chronic lymphocytic leukemia: The possible role of fludarabine and the Epstein-Barr virus in its pathogenesis
    • Th ornton PD, Bellas C, Santon A, et al. Richter'stransformation of chronic lymphocytic leukemia: the possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res 2005; 29: 389-395.
    • (2005) Leuk Res , vol.29 , pp. 389-395
    • Thornton, P.D.1    Bellas, C.2    Santon, A.3
  • 16
    • 57449116575 scopus 로고    scopus 로고
    • 14q32 translocations and risk of Richter transformation in chronic lymphocytic leukaemia
    • Deambrogi C, Cresta S, Cerri M, et al. 14q32 translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br JHaematol 2008; 144: 131-133.
    • (2008) Br JHaematol , vol.144 , pp. 131-133
    • Deambrogi, C.1    Cresta, S.2    Cerri, M.3
  • 17
    • 47049131482 scopus 로고    scopus 로고
    • CD38 gene polymorphism and chronic lymphocytic leukemia: Arole in transformation to Richter syndrome?
    • Aydin S, Rossi D, Bergui L, et al. CD38 gene polymorphism and chronic lymphocytic leukemia: arole in transformation to Richter syndrome? Blood 2008; 111: 5646-5653.
    • (2008) Blood , vol.111 , pp. 5646-5653
    • Aydin, S.1    Rossi, D.2    Bergui, L.3
  • 18
    • 67650393955 scopus 로고    scopus 로고
    • Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
    • Rossi D, Spina V, Cerri M, et al. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009; 15: 4415-4422.
    • (2009) Clin Cancer Res , vol.15 , pp. 4415-4422
    • Rossi, D.1    Spina, V.2    Cerri, M.3
  • 19
    • 34848904482 scopus 로고    scopus 로고
    • Risk factors for development of asecond lymphoid malignancy in patients with chronic lymphocytic leukemia
    • Maddocks-Christianson K, Slager SL, Zent CS, et al. Risk factors for development of asecond lymphoid malignancy in patients with chronic lymphocytic leukemia. Br JHaematol 2007; 139: 398-404.
    • (2007) Br JHaematol , vol.139 , pp. 398-404
    • Maddocks-Christianson, K.1    Slager, S.L.2    Zent, C.S.3
  • 20
    • 58249093949 scopus 로고    scopus 로고
    • Increased incidence of transformation and myelodysplasis/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs
    • Leleu X, Soumerai J, Rocarro A, et al. Increased incidence of transformation and myelodysplasis/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs. JClin Oncol 2008; 27: 250-255.
    • (2008) JClin Oncol , vol.27 , pp. 250-255
    • Leleu, X.1    Soumerai, J.2    Rocarro, A.3
  • 21
    • 12344338189 scopus 로고    scopus 로고
    • Second malignancies and Richter'ssyndrome in patients with chronic lymphocytic leukemia
    • Robak T. Second malignancies and Richter'ssyndrome in patients with chronic lymphocytic leukemia. Hematology 2004; 9: 387-400.
    • (2004) Hematology , vol.9 , pp. 387-400
    • Robak, T.1
  • 22
    • 9144241003 scopus 로고    scopus 로고
    • Second malignancies and Richter'ssyndrome in patients with chronic lymphocytic leukaemia treated with cladribine
    • Robak T, Blonski JZ, Gora-Tybor J, et al. Second malignancies and Richter'ssyndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur JCancer 2004; 40: 383-389.
    • (2004) Eur JCancer , vol.40 , pp. 383-389
    • Robak, T.1    Blonski, J.Z.2    Gora-Tybor, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.